HIGHLIGHTS
- who: Ameet A. Chimote from the Guangzhou Medical University, China have published the Article: Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19, in the Journal: (JOURNAL)
- what: By demonstrating the differentially regulated pathways as a result of dexamethasone treatment in severe COVID-19 patients, the authors provide evidence that decreased expression of Kv1.3 channels in PBMCs mediates the immunosuppressive effect of dexamethasone. This study was designed to investigate the immune and molecular mechanisms involved in COVID-19 disease progression and determine the beneficial effects of dexamethasone in severely ill . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.